Literature DB >> 23364263

Cyclic AMP-mediated pleiotropic effects of glucagon-like peptide-1 receptor activation. Focus on "Exendin-4 attenuates high glucose-induced cardiomyocyte apoptosis via inhibition of endoplasmic reticulum stress and activation of SERCA2a".

Yumei Ye, Yochai Birnbaum.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23364263     DOI： 10.1152/ajpcell.00419.2012

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN： 0363-6143            Impact factor:   4.249


× No keyword cloud information.
  4 in total

1.  Novel fusion of GLP-1 with a domain antibody to serum albumin prolongs protection against myocardial ischemia/reperfusion injury in the rat.

Authors:  Weike Bao; Lucy J Holt; Rob D Prince; Gavin X Jones; Karpagam Aravindhan; Mathew Szapacs; April M Barbour; Larry J Jolivette; John J Lepore; Robert N Willette; Elena DeAngelis; Beat M Jucker
Journal:  Cardiovasc Diabetol       Date:  2013-10-14       Impact factor: 9.951

2.  TGR5 activation ameliorates hyperglycemia-induced cardiac hypertrophy in H9c2 cells.

Authors:  Kai-Chun Cheng; Wei-Ting Chang; Feng Yu Kuo; Zhih-Cherng Chen; Yingxiao Li; Juei-Tang Cheng
Journal:  Sci Rep       Date:  2019-03-06       Impact factor: 4.379

3.  Amelioration of muscle wasting by glucagon-like peptide-1 receptor agonist in muscle atrophy.

Authors:  Yeonhee Hong; Jong Han Lee; Kwang Won Jeong; Cheol Soo Choi; Hee-Sook Jun
Journal:  J Cachexia Sarcopenia Muscle       Date:  2019-04-24       Impact factor: 12.910

4.  Glucagon-like peptide 1 receptor activation regulates cocaine actions and dopamine homeostasis in the lateral septum by decreasing arachidonic acid levels.

Authors:  I A Reddy; J A Pino; P Weikop; N Osses; G Sørensen; T Bering; C Valle; R J Bluett; K Erreger; G Wortwein; J G Reyes; D Graham; G D Stanwood; T A Hackett; S Patel; A Fink-Jensen; G E Torres; A Galli
Journal:  Transl Psychiatry       Date:  2016-05-17       Impact factor: 6.222
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.